Whole-body MRI within a surveillance program for carriers with clinically actionable germline TP53 variants - the Swedish constitutional TP53 study SWEP53
ConclusionsThe SWEP53 is the first structured national surveillance program including radiological and clinical routines forTP53 mutation carriers in the Scandinavian setting. The aim of this publication is to present and describe the ongoing Swedish surveillance study to encourage the initiation of similar studies and to contribute to the knowledge of adequate clinical handling of these cancer prone families.Trial registrationTrial registration number:ISRCTN13103571, retrospectively registered on 14/10/2019.
Source: Hereditary Cancer in Clinical Practice - Category: Cancer & Oncology Source Type: research
More News: Brain | Brain Cancers | Cancer | Cancer & Oncology | Children | Corticosteroid Therapy | Genetics | Neurology | PET Scan | Study | Sweden Health | Ultrasound